Advertisement

Cognitive Frailty in Older People with Type 2 Diabetes Mellitus: the Central Role of Hypoglycaemia and the Need for Prevention

  • A. H. AbdelhafizEmail author
  • A. J. Sinclair
Other Forms of Diabetes and Its Complications (JJ Nolan and H Thabit, Section Editors)
  • 76 Downloads
Part of the following topical collections:
  1. Topical Collection on Other Forms of Diabetes and Its Complications

Abstract

Purpose of Review

To highlight the central role of hypoglycaemia in the causation of cognitive frailty and explore ways of recognition and prevention of hypoglycaemia.

Recent Findings

Cognitive frailty is an emerging new concept defined as the concomitant presence of physical frailty and cognitive impairment. In older people with diabetes, cognitive frailty is associated with an increased risk of mortality greater than from either physical frailty or cognitive impairment alone. Hypoglycaemia is directly associated with increased risk of cognitive impairment and physical frailty which are the two components of cognitive frailty. The incidence of hypoglycaemia in older people with diabetes is rising and hypoglycaemia-related hospitalisation has overtaken that of hyperglycaemia.

Summary

Recognition of hypoglycaemic episodes in old age remains challenging which leads to misdiagnoses and under-reporting. Therefore, hypoglycaemia prevention strategies are needed. Research is still required to investigate whether prevention of hypoglycaemia would lead to a reduction in the incidence of cognitive frailty.

Keywords

Cognition Frailty Hypoglycaemia Older people Diabetes mellitus 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRefGoogle Scholar
  2. 2.
    Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66:1210–5.CrossRefGoogle Scholar
  3. 3.
    Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;10:819–29.CrossRefGoogle Scholar
  4. 4.
    Thein FS, Li Y, Nyunt MSZ, Gao Q, Wee SL, Ng TP. Physical frailty and cognitive impairment is associated with diabetes and adversely impact functional status and mortality. Postgrad Med. 2018;130:561–7.CrossRefGoogle Scholar
  5. 5.
    Panza F, D'Introno A, Colacicco AM, et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging. 2006;27:933–40.CrossRefGoogle Scholar
  6. 6.
    •• Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: rational and definition from an (IANA/IAGG) international consensus group. J Nutr Health Aging. 2013;9:726–34. This is a consensus report introducing the new concept of cognitive frailty. CrossRefGoogle Scholar
  7. 7.
    Thorpe CT, Thorpe JM, Kind AJ, et al. Receipt of monitoring of diabetes mellitus in older adults with comorbid dementia. J Am Geriatr Soc. 2012;60:644–51.CrossRefGoogle Scholar
  8. 8.
    Bordier L, Doucet J, Boudet J, Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab. 2014;40:331–7.CrossRefGoogle Scholar
  9. 9.
    Gadsby R, Barker P, Sinclair A. People living with diabetes resident in nursing homes–assessing levels of disability and nursing needs. Diabet Med. 2011;28:778–80.CrossRefGoogle Scholar
  10. 10.
    Passaro A, Nora ED, Morieri ML, et al. Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population. J Gerontol A Biol Sci Med Sci. 2015;70:294–302.CrossRefGoogle Scholar
  11. 11.
    Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, et al. Is insulin resistant brain state a central feature of the metabolic cognitive syndrome? J Alzheimers Dis. 2010;21:57–63.CrossRefGoogle Scholar
  12. 12.
    Li J, Wang YJ, Zhang M, the Chongqing Ageing Study Group, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–91.CrossRefGoogle Scholar
  13. 13.
    Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484–91.CrossRefGoogle Scholar
  14. 14.
    Wong E, Backholer K, Gearon E, Harding J, Freak-Poli R, Stevenson C, et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1:106–14.CrossRefGoogle Scholar
  15. 15.
    Chiu CJ, Wray LA. Physical disability trajectories in older Americans with and without diabetes: the role of age, gender, race or ethnicity, and education. Gerontologist. 2011;51:51–63.CrossRefGoogle Scholar
  16. 16.
    Maggi S, Noale M, Gallina P, Marzari C, Bianchi D, Limongi F, et al. Physical disability among older Italians with diabetes. The ILSA study. Diabetologia. 2004;47:1957–62.CrossRefGoogle Scholar
  17. 17.
    Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Health, aging, and body composition study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30:1507–12.CrossRefGoogle Scholar
  18. 18.
    Lee S, Lee S, Harada K, Bae S, Makizako H, Doi T, et al. Relationship between chronic kidney disease with diabetes or hypertension and frailty in community-dwelling Japanese older adults. Geriatr Gerontol Int. 2017;17:1527–33.PubMedGoogle Scholar
  19. 19.
    Morley JE, Malmstrom TK, Rodriguez-Manas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014;15:853–9.CrossRefGoogle Scholar
  20. 20.
    Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62A:731–7.Google Scholar
  21. 21.
    Gruenewald TL, Seeman TE, Karlamangla AS, Sarkisian CA. Allostatic load and frailty in older adults. J Am Geriatr Soc. 2009;57:1525–31.CrossRefGoogle Scholar
  22. 22.
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56A:M146–M56.CrossRefGoogle Scholar
  23. 23.
    Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95.CrossRefGoogle Scholar
  24. 24.
    Pialoux T, Goyard J, Lesourd B. Screening tools for frailty in primary health care: a systematic review. Geriatr Gerontol Int. 2012;12:189–97.CrossRefGoogle Scholar
  25. 25.
    Heuberger RA. The frailty syndrome: a comprehensive review. J Nutr Gerontol Geriatr. 2011;30:315–68.CrossRefGoogle Scholar
  26. 26.
    Wou F, Conroy S. The frailty syndrome. Medicine. 2013;41:13–5.CrossRefGoogle Scholar
  27. 27.
    De Vries NM, Staal JB, van Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev. 2011;10:104–14.CrossRefGoogle Scholar
  28. 28.
    Jafari B, Britton ME. Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention. J Pharm Pract Res. 2015;45:459–69.CrossRefGoogle Scholar
  29. 29.
    Tschöpe D, Bramlage P, Binz C, Krekler M, Deeg E, Gitt AK. Incidence and predictors of hypoglycaemia in type 2 diabetes. BMC Endocr Disord. 2012;12.  https://doi.org/10.1186/1472-6823-12-23.
  30. 30.
    Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycaemia. Cardiovasc Diabetol. 2012;11:122.  https://doi.org/10.1186/1475-2840-11-122.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Chen LK, Lin MH, Lai HY, Hwang SJ. Care of patients with diabetes mellitus in long-term care facilities in Taiwan: diagnosis, glycemic control, hypoglycemia, and functional status. J Am Geriatr Soc. 2008;56:1975–6.CrossRefGoogle Scholar
  32. 32.
    Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab. 2009;297:E194–201.CrossRefGoogle Scholar
  33. 33.
    Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173:1300–6.CrossRefGoogle Scholar
  34. 34.
    Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk ofdementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.CrossRefGoogle Scholar
  35. 35.
    Lin CH, Sheu WHH. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med. 2013;273:102–10.CrossRefGoogle Scholar
  36. 36.
    Chin SO, Rhee SY, Chon S, Baik SH, Park Y, Nam MS, et al. Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: an analysis based on the Korea National Diabetes Program Cohort. Diabetes Res Clin Pract. 2016;122:54–61.CrossRefGoogle Scholar
  37. 37.
    • Mehta HB, Mehta V, Goodwin JS. Association of hypoglycemia with subsequent dementia in older patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci. 2017;72:1110–6. This is a large study confirming the relationship between hypoglycaemia and incident dementia in a dose guarded effect. PubMedGoogle Scholar
  38. 38.
    Feinkohl I, Aung PP, Keller M, Robertson CM, Morling JR, McLachlan S, et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2014;37:507–15.CrossRefGoogle Scholar
  39. 39.
    Haroon NN, Austin PC, Shah BR, Wu J, Gill SS, Booth GL. Risk of dementia in seniors with newly diagnosed diabetes: a population-based study. Diabetes Care. 2015;38:1868–75.CrossRefGoogle Scholar
  40. 40.
    Duning T, van den Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J, et al. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care. 2010;33:639–44.CrossRefGoogle Scholar
  41. 41.
    Aung PP, Strachan MW, Frier BM, Butcher I, Deary IJ, Price JF. Severe hypoglycaemia and late-life cognitive ability in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabet Med. 2012;29:328–36.CrossRefGoogle Scholar
  42. 42.
    Gao Y, Xiao Y, Miao R, Zhao J, Zhang W, Huang G, et al. The characteristic of cognitive function in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015;109:299–305.CrossRefGoogle Scholar
  43. 43.
    Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR, et al. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) cohort study. Diabetologia. 2018;61:1956–65.CrossRefGoogle Scholar
  44. 44.
    Alonso MAC, Santos JMM, Vilanova MI, Reino ADP. Over effective control of glycemic levels could cause cognitive decline in diabetic geriatric population. Neurol Neurosci Res. 2017;1:3.  https://doi.org/10.24983/scitemed.nnr.2017.00047.CrossRefGoogle Scholar
  45. 45.
    Wang F, Zhao M, Han Z, Li D, Zhang S, Zhang Y, et al. Long-term subclinical hyperglycemia and hypoglycemia as independent risk factors for mild cognitive impairment in elderly people. Tohoku J Exp Med. 2017;242:121–8.CrossRefGoogle Scholar
  46. 46.
    Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 2008;51:241–8.CrossRefGoogle Scholar
  47. 47.
    Bruce DG, Davis WA, Casey GP, Clarnette RM, Brown SGA, Jacobs IG, et al. Severe hypoglycemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia. 2009;52:1808–15.CrossRefGoogle Scholar
  48. 48.
    Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77.CrossRefGoogle Scholar
  49. 49.
    de Galan BE, Zoungas S, Chalmers J, ADVANCE Collaborative Group, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2009;52:2328–36.CrossRefGoogle Scholar
  50. 50.
    Pilotto A, Noale M, Maggi S, Addante F, Tiengo A, Cavallo Perin P, et al. Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients. Biomed Res Int. 2014.  https://doi.org/10.1155/2014/906103.
  51. 51.
    • Zaslavsky O, Walker RL, Crane PK, Gray SL, Larson EB. Glucose levels and risk of frailty. J Gerontol A Biol Sci Med Sci. 2016;71:1223–9. This is a large prospective study that investigated the relationship between blood glucose levels and incident frailty in persons with or without diabetes. CrossRefGoogle Scholar
  52. 52.
    Yanagita I, Fujihara Y, Eda T, Tajima M, Yonemura K, Kawajiri T, et al. Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients. J Diabetes Investig. 2018;9:419–25.CrossRefGoogle Scholar
  53. 53.
    Morita T, Okuno T, Himeno T, Watanabe K, Nakajima K, Koizumi Y, et al. Glycemic control and disability-free survival in hypoglycemic agent-treated community-dwelling older patients with type 2 diabetes mellitus. Geriatr Gerontol Int. 2017;17:1858–65.CrossRefGoogle Scholar
  54. 54.
    de Decker L, Hanon O, Boureau AS, Chapelet G, Dibon C, Pichelin M, et al. Association between hypoglycemia and the burden of comorbidities in hospitalized vulnerable older diabetic patients: a cross-sectional, population-based study. Diabetes Ther. 2017;8:1405–13.CrossRefGoogle Scholar
  55. 55.
    Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, et al. Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: results from the DIMORA study. Metabolism. 2015;64:1500–6.CrossRefGoogle Scholar
  56. 56.
    Mattishent K, Loke YK. Meta-analysis: association between hypoglycaemia and serious adverse events in older patients. J Diabetes Complicat. 2016;30:811–8.CrossRefGoogle Scholar
  57. 57.
    Hung YC, Lin CC, Chen HJ, Chang MP, Huang KC, Chen YH, et al. Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study. Osteoporos Int. 2017;28:2053–60.CrossRefGoogle Scholar
  58. 58.
    Robertsona DA, Savva GM, Kenny RA. Frailty and cognitive impairment—a review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12:840–51.CrossRefGoogle Scholar
  59. 59.
    Mattishent K, Loke YK. Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18:135–41.CrossRefGoogle Scholar
  60. 60.
    Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2010;65A:377–81.CrossRefGoogle Scholar
  61. 61.
    Cheng PC, Hsu SR, Tu ST, Cheng YC, Liu YH. Body mass index influences the plasma glucose concentration during iatrogenic hypoglycemia in people with type 2 diabetes mellitus: a cross-sectional study. PeerJ. 2018;6:e4348.  https://doi.org/10.7717/peerj.4348.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Abdelhafiz AH, Koay L, Sincalir AJ. The emergence of frailty may lead to a state of burnt out type 2 diabetes. J Frailty Aging. 2016;5:162–7.PubMedGoogle Scholar
  63. 63.
    Gorska-Ciebiada M, Saryusz-Wolska M, Ciebiada M, Loba J. Mild cognitive impairment and depressive symptoms in elderly patients with diabetes: prevalence, risk factors, and comorbidity. J Diabetes Res. 2014;2014:179648–7.  https://doi.org/10.1155/2014/179648.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Nicolucci A, Pintaudi B, Rossi MC, Messina R, Dotta F, Frontoni S, et al. The social burden of hypoglycemia in the elderly. Acta Diabetol. 2015;52:677–85.CrossRefGoogle Scholar
  65. 65.
    Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–7.CrossRefGoogle Scholar
  66. 66.
    Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, et al. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord. 2012;12.  https://doi.org/10.1186/1472-6823-12-5.
  67. 67.
    Hope SV, Taylor PJ, Shields BM, Hattersley AT, Hamilton W. Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia. Prim Care Diabetes. 2018;12:139–46.CrossRefGoogle Scholar
  68. 68.
    Lipska KJ, Krumholz H, Soones T, et al. Polypharmacy in the aging patient. A review of glycemic control in older adults with type 2 diabetes. JAMA. 2016;315:1034–45.CrossRefGoogle Scholar
  69. 69.
    IDF Global Guideline for Managing Older People with Type 2 Diabetes. 2013. www.idf.org/e-library/guidelines/78-global-guideline-for-managing-older-people-with-type-2-diabetes.html. Accessed 7 Feb 2019.
  70. 70.
    Sinclair A, Morley JE, Rodriguez-Mañas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. 2012;13:497–502.Google Scholar
  71. 71.
    Sinclair AJ, Abdelhafiz A, Dunning T, Izquierdo M, Rodriguez Manas L, Bourdel-Marchasson I, et al. An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J Frailty Aging. 2018;7:10–20.PubMedGoogle Scholar
  72. 72.
    Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L. European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab. 2011;37(Suppl 3):S27–38.CrossRefGoogle Scholar
  73. 73.
    American Diabetes Association. 11. Older adults: standards of medical care in diabetes—2018. Diabetes Care. 2018;41:S119–25.CrossRefGoogle Scholar
  74. 74.
    Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171:362–4.CrossRefGoogle Scholar
  75. 75.
    Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, et al. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. PLoS One. 2014;9:e97384.CrossRefGoogle Scholar
  76. 76.
    Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:476–86.CrossRefGoogle Scholar
  77. 77.
    Cui X, Amir A, Manor BD, et al. Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes. Plos One. 2014;9:e 86284.CrossRefGoogle Scholar
  78. 78.
    García-Casares N, García-Arnés JA, Gómez-Huelgas R, Valdivielso-Felices P, García-Arias C, González-Santos P. Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer’s disease? Rev Neurol. 2014;59:517–24.PubMedGoogle Scholar
  79. 79.
    Galimberti D, Scarpini E. Pioglitazone for the treatment of Alzheimer’s disease. Expert Opin Investig Drugs. 2017;26:97–101.CrossRefGoogle Scholar
  80. 80.
    Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175:356–62.CrossRefGoogle Scholar
  81. 81.
    Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015;38:588–95.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Munshi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. Simplification of insulin regimen in older adults and risk of hypoglycemia. JAMA Intern Med. 2016;176:1023–5.CrossRefGoogle Scholar
  83. 83.
    Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska ME, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med. 2018;379:547–56.CrossRefGoogle Scholar
  84. 84.
    Bunn F, Burn AM, Robinson L, Poole M, Rait G, Brayne C, et al. Healthcare organisation and delivery for people with dementia and comorbidity: a qualitative study exploring the views of patients, carers and professionals. BMJ Open. 2017;7:e013067.CrossRefGoogle Scholar
  85. 85.
    Sinclair A. Diabetes care for older people: a practical view on management. Diabetes and Primary Care. 2011;13:29–38.Google Scholar
  86. 86.
    Gulli G, Frasson S, Borzı’ V, et al. Effectiveness of an educational intervention on the management of type 2 diabetic patients hospitalized in Internal Medicine: results from the FADOI-DIAMOND study. Acta Diabetol. 2014;51:765–70.CrossRefGoogle Scholar
  87. 87.
    Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, Kirsh S, Kullgren JT, Prenovost K, et al. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia: national survey of veterans affairs health care professionals. JAMA Intern Med. 2015;175:1994–6.CrossRefGoogle Scholar
  88. 88.
    Karter AJ, Warton EM, Lipska KJ, et al. Development and validation of a tool to identify patients with type 2 diabetes at high risk of hypoglycemia-related emergency department or hospital use. JAMA Intern Med. 2017;36:3535–42.Google Scholar
  89. 89.
    Vimalananda VG, DeSotto K, Chen T, Mullakary J, Schlosser J, Archambeault C, et al. A quality improvement program to reduce potential overtreatment of diabetes among veterans at high risk of hypoglycemia. Diabetes Spectr. 2017;30:211–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Geriatric MedicineRotherham General HospitalRotherhamUK
  2. 2.Foundation for Diabetes Research in Older PeopleDiabetes Frail LtdDroitwich SpaUK
  3. 3.Kings CollegeLondonUK

Personalised recommendations